Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
Seer (Nasdaq: SEER) has been ranked No. 57 on the 2024 Deloitte Technology Fast 500™, achieving a remarkable 2,440% revenue growth. The company attributes this growth to increased adoption of its Proteograph Product Suite and customer discoveries across neurodegenerative disease, cancer, and metabolic disease. Key achievements include launching a technology access center in Europe, platform usage on the SpaceX Inspiration4 mission, and establishing a co-marketing agreement with Thermo Fisher Scientific. This marks Seer's second consecutive appearance on the list, improving from their No. 5 ranking in 2023.
Seer (Nasdaq: SEER) è stata classificata al 57° posto nella Deloitte Technology Fast 500™ del 2024, registrando una straordinaria crescita dei ricavi del 2.440%. L'azienda attribuisce questa crescita all'aumento dell'adozione della sua Proteograph Product Suite e alle scoperte dei clienti nel campo delle malattie neurodegenerative, del cancro e delle malattie metaboliche. Tra i principali risultati si annoverano il lancio di un centro di accesso alla tecnologia in Europa, l'utilizzo della piattaforma nella missione SpaceX Inspiration4 e la stipula di un accordo di co-marketing con Thermo Fisher Scientific. Questo segna la seconda apparizione consecutiva di Seer nella lista, migliorando rispetto al quinto posto ottenuto nel 2023.
Seer (Nasdaq: SEER) ha sido clasificada en la posición 57 en el Deloitte Technology Fast 500™ de 2024, logrando un notable crecimiento de ingresos del 2,440%. La compañía atribuye este crecimiento a una mayor adopción de su Proteograph Product Suite y a los descubrimientos de los clientes en enfermedades neurodegenerativas, cáncer y enfermedades metabólicas. Los logros clave incluyen el lanzamiento de un centro de acceso a la tecnología en Europa, el uso de la plataforma en la misión SpaceX Inspiration4 y el establecimiento de un acuerdo de co-marketing con Thermo Fisher Scientific. Esta es la segunda aparición consecutiva de Seer en la lista, mejorando desde su posición 5 en 2023.
Seer (Nasdaq: SEER)는 2024년 Deloitte Technology Fast 500™에서 57위로 선정되었으며, 놀라운 2,440%의 수익 성장을 기록하였습니다. 회사는 이러한 성장을 Proteograph Product Suite의 채택 증가와 신경퇴행성 질환, 암, 대사 질환에서 고객의 발견에 기인한다고 분석하고 있습니다. 주요 성과로는 유럽에서 기술 접근 센터를 개설하고, SpaceX Inspiration4 미션에서 플랫폼 사용 및 Thermo Fisher Scientific과의 공동 마케팅 계약 체결이 있습니다. 이는 Seer가 리스트에 두 번째로 연속적으로 등장하는 것으로, 2023년 5위에서 개선된 순위입니다.
Seer (Nasdaq: SEER) a été classée 57ème dans le Deloitte Technology Fast 500™ de 2024, réalisant une croissance des revenus de 2,440% remarquable. L'entreprise attribue cette croissance à l'adoption accrue de sa Proteograph Product Suite et aux découvertes de ses clients dans le domaine des maladies neurodégénératives, du cancer et des maladies métaboliques. Les réalisations clés incluent le lancement d'un centre d'accès à la technologie en Europe, l'utilisation de la plateforme lors de la mission SpaceX Inspiration4 et l'établissement d'un accord de co-marketing avec Thermo Fisher Scientific. Cela marque la deuxième apparition consécutive de Seer sur la liste, améliorant son classement par rapport à la 5ème place en 2023.
Seer (Nasdaq: SEER) wurde im Deloitte Technology Fast 500™ für 2024 an 57. Stelle eingestuft und erzielte ein bemerkenswertes Umsatzwachstum von 2.440%. Das Unternehmen führt dieses Wachstum auf die vermehrte Nutzung seines Proteograph Product Suite und Entdeckungen der Kunden im Bereich neurodegenerative Erkrankungen, Krebs und Stoffwechselerkrankungen zurück. Zu den wichtigsten Erfolgen gehören die Eröffnung eines Technologiezugangszentrums in Europa, die Nutzung der Plattform während der SpaceX Inspiration4-Mission und der Abschluss einer Co-Marketing-Vereinbarung mit Thermo Fisher Scientific. Dies markiert Seers zweite aufeinanderfolgende Nennung in der Liste, nachdem sie sich von Platz 5 im Jahr 2023 verbessert haben.
- Achieved 2,440% revenue growth over three years
- Secured co-marketing and sales agreement with Thermo Fisher Scientific
- Expanded international presence with European technology access center
- Demonstrated platform adoption in space research (SpaceX Inspiration4)
- None.
Insights
The
The expansion into Europe through a technology access center and the SpaceX mission participation demonstrate growing market acceptance and validation of Seer's Proteograph platform. However, the company's current market cap of
Attributes 2,
REDWOOD CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it ranked No. 57 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 30th year. Seer grew 2,
Seer’s President and CFO, David Horn, credits increased adoption of Seer’s Proteograph Product Suite, as well as new discoveries made by its customers across neurodegenerative disease, cancer, and metabolic disease, with the company’s 2,
"This has been an exciting year for Seer, from the launch of our technology access center in Europe, to seeing our Proteograph platform used by astronauts on the SpaceX Inspiration4 mission, to the recent announcement of our co-marketing and sales agreement with Thermo Fisher Scientific,” Horn said. “We’re proud to see continuing validation of our work providing customers and the broader scientific community with the power to enable deep proteomic insights at a scale and price point that hasn’t been possible before."
Seer previously ranked No. 5 as a Technology Fast 500 award winner for 2023.
Overall, 2024 Technology Fast 500 companies achieved revenue growth ranging from
About the 2024 Deloitte Technology Fast 500:
Now in its 30th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2020 to 2023.
In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least US
About Seer:
Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.
Media Contact: Patrick Schmidt pr@seer.bio
Investor Contact: Carrie Mendivil investor@seer.bio
About Deloitte:
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world’s most admired brands, including nearly
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.
FAQ
What was Seer's (SEER) ranking on the 2024 Deloitte Technology Fast 500?
What was Seer's (SEER) revenue growth percentage in the 2024 Deloitte Technology Fast 500?
What major partnership did Seer (SEER) announce in 2024?
How did Seer's (SEER) 2024 Deloitte ranking compare to 2023?
